Meet BioConnection at CPHI 2024

We are pleased to announce that we will be present at CPHI in Milan, Italy, from October 08-10, 2024! Visit us at Fiera Milano, stand number 7F50, to explore new opportunities and learn more about our solutions for injectable (bio)pharmaceutical products from our FDA and EMA-certified facility. We specialize in Fill Finish for both liquid and freeze-dried products in vials and syringes.

Date:

October 08-10
2024

Location:

Fiera, Milan, Italy

Stand number:

7F50

These team members will be there to connect with you:

Richard Sewalt

Ruben Teeuwen

Alexander Willemse

Anna-Myra Koopmans

Marco Jaspers

Maudy van den Berg

Marta Kijanka

Okan Özkanli

Connect on forehand?

Please send us your personal information.

About BioConnection

BioConnection (BCO) is a specialized contract manufacturing organization (specialized CMO) serving the pharmaceutical industry. Operating from our FDA and EMA-certified facility in Oss, North Brabant, we specialize in producing injectable (bio)pharmaceutical products. Our services cover Chemistry, Manufacturing, and Controls (CMC), including drug product manufacturing process development, Fill & Finish for liquid, and freeze-drying (lyophilization) in vials and syringes. We also provide specialized small-scale (hand fill) production for personalized medicines, ensuring precision and flexibility.

At BioConnection, we support the entire drug life cycle, from producing materials for toxicology studies to clinical material manufacturing (Phase I-III) and final market production (up to 500 L). We excel in seamless project transitions, including internal technical transfers, scale-ups, and efficient preparation for Process Performance Qualification (PPQ) campaigns before market launch.

Ultimately, BioConnection drives healthcare innovation through strategic collaborations and emerging trend partnerships. While we do not engage in pharmacovigilance, our drug products are manufactured to meet strict quality standards that support this crucial aspect of the drug life cycle. We are committed to global health initiatives and sustainable manufacturing practices, improving access to life-saving medicines worldwide. Therefore, we would be delighted to discuss how we can support your projects.